Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Greenlight Captial
GLRE
$514M
| $2.24M | ﹤0.01% |
102,900
-171,900
| -63% | -$3.42M |
|
2152
Escalade
ESCA
$276M
| $2.23M | ﹤0.01% |
189,800
-3,000
| -2% | -$37.1K |
|
|
SEMI
2153
DELISTED
SunEdison Semiconductor Limited
SEMI
| $2.23M | ﹤0.01% |
343,800
-40,300
| -10% | -$242K |
|
2154
Par Pacific Holdings
PARR
$4.02B
| $2.23M | ﹤0.01% |
118,600
+8,500
| +8% | +$182K |
|
|
CUDA
2155
DELISTED
Barracuda Networks, Inc.
CUDA
| $2.22M | ﹤0.01% |
144,300
-60,300
| -29% | -$768K |
|
|
CIM
2156
Chimera Investment
CIM
$988M
| $2.22M | ﹤0.01% |
54,400
+46,067
| +553% | +$1.79M |
|
2157
Equinix
EQIX
$109B
| $2.22M | ﹤0.01% |
6,700
-231,239
| -97% | -$70.3M |
|
|
SNC
2158
DELISTED
State National Companies, Inc.
SNC
| $2.21M | ﹤0.01% |
175,700
+101,300
| +136% | +$1.09M |
|
2159
Perion Network
PERI
$385M
| $2.21M | ﹤0.01% |
365,913
-6,420
| -2% | -$44.9K |
|
2160
Piper Sandler
PIPR
$5.41B
| $2.21M | ﹤0.01% |
+178,000
| New | +$1.8M |
|
2161
Sierra Bancorp
BSRR
$532M
| $2.2M | ﹤0.01% |
121,400
+28,300
| +30% | +$506K |
|
|
HMTV
2162
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $2.2M | ﹤0.01% |
167,600
+76,100
| +83% | +$1.05M |
|
2163
Allot
ALLT
$383M
| $2.2M | ﹤0.01% |
420,400
+119,600
| +40% | +$594K |
|
|
UPL
2164
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $2.2M | ﹤0.01% |
4,408,798
+3,397,367
| +336% | +$4.01M |
|
|
ICAD
2165
DELISTED
iCAD Inc
ICAD
| $2.19M | ﹤0.01% |
430,360
+9,261
| +2% | +$41.3K |
|
2166
Dick's Sporting Goods
DKS
$18.1B
| $2.19M | ﹤0.01% |
46,900
-188,200
| -80% | -$7.65M |
|
|
NTUS
2167
DELISTED
Natus Medical Inc
NTUS
| $2.19M | ﹤0.01% |
56,945
-81,300
| -59% | -$3.03M |
|
|
TPH
2168
DELISTED
Tri Pointe Homes
TPH
| $2.19M | ﹤0.01% |
185,536
-65,540
| -26% | -$692K |
|
|
KSPN
2169
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
| $2.19M | ﹤0.01% |
30,020
+360
| +1% | +$25.7K |
|
|
SNCR
2170
DELISTED
Synchronoss Technologies
SNCR
| $2.18M | ﹤0.01% |
7,489
+4,889
| +188% | +$1.27M |
|
2171
Chefs' Warehouse
CHEF
$4.45B
| $2.18M | ﹤0.01% |
107,400
+42,100
| +64% | +$694K |
|
|
LEAF
2172
DELISTED
Leaf Group Ltd.
LEAF
| $2.17M | ﹤0.01% |
434,300
+42,910
| +11% | +$214K |
|
|
ARLZ
2173
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $2.17M | ﹤0.01% |
+610,819
| New | +$3.15M |
|
2174
Timberland Bancorp
TSBK
$358M
| $2.16M | ﹤0.01% |
171,200
+9,200
| +6% | +$115K |
|
|
IRS
2175
IRSA Inversiones y Representaciones
IRS
$1.24B
| $2.16M | ﹤0.01% |
149,920
-323,098
| -68% | -$3.6M |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.